Cargando…
Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies
This evidence-based review will discuss the current standard of adjuvant chemotherapy for resected high-risk colon cancer and address existing controversies including strategies for risk-stratification, the status of targeted therapy, treatment of the elderly and the optimal duration of therapy.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202614/ https://www.ncbi.nlm.nih.gov/pubmed/25336789 http://dx.doi.org/10.4103/0971-5851.142032 |